X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13580) 13580
Book Chapter (30) 30
Magazine Article (28) 28
Newsletter (16) 16
Conference Proceeding (11) 11
Dissertation (6) 6
Book / eBook (3) 3
Government Document (3) 3
Web Resource (3) 3
Newspaper Article (2) 2
Publication (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9882) 9882
science & technology (6023) 6023
life sciences & biomedicine (5859) 5859
male (5810) 5810
female (5689) 5689
vinblastine - administration & dosage (5254) 5254
antineoplastic combined chemotherapy protocols - therapeutic use (4577) 4577
middle aged (4178) 4178
adult (4081) 4081
oncology (3440) 3440
animals (3406) 3406
vinblastine - pharmacology (3379) 3379
aged (3323) 3323
vinblastine - analogs & derivatives (3298) 3298
vinblastine - therapeutic use (2861) 2861
cisplatin - administration & dosage (2300) 2300
vinblastine (2230) 2230
vinblastine - adverse effects (1836) 1836
doxorubicin - administration & dosage (1670) 1670
antineoplastic combined chemotherapy protocols - adverse effects (1668) 1668
bleomycin - administration & dosage (1592) 1592
treatment outcome (1590) 1590
lung neoplasms - drug therapy (1554) 1554
hodgkin disease - drug therapy (1513) 1513
chemotherapy (1490) 1490
combined modality therapy (1346) 1346
adolescent (1327) 1327
mice (1284) 1284
neoplasm staging (1255) 1255
vinorelbine (1198) 1198
carcinoma, non-small-cell lung - drug therapy (1154) 1154
abridged index medicus (1091) 1091
antineoplastic combined chemotherapy protocols - administration & dosage (1032) 1032
cancer (966) 966
prognosis (953) 953
rats (936) 936
time factors (927) 927
colchicine - pharmacology (922) 922
antineoplastic agents - therapeutic use (915) 915
breast neoplasms - drug therapy (908) 908
drug administration schedule (892) 892
survival rate (859) 859
pharmacology & pharmacy (847) 847
vincristine - administration & dosage (830) 830
methotrexate - administration & dosage (823) 823
deoxycytidine - analogs & derivatives (812) 812
dacarbazine - administration & dosage (792) 792
drug therapy, combination (777) 777
follow-up studies (763) 763
dose-response relationship, drug (762) 762
cyclophosphamide - administration & dosage (747) 747
survival analysis (728) 728
prednisone - administration & dosage (711) 711
disease-free survival (708) 708
lung neoplasms - pathology (668) 668
aged, 80 and over (664) 664
procarbazine - administration & dosage (658) 658
retrospective studies (653) 653
deoxycytidine - administration & dosage (643) 643
child (624) 624
remission induction (617) 617
neoplasm metastasis (611) 611
etoposide - administration & dosage (609) 609
microtubules - drug effects (589) 589
doxorubicin - therapeutic use (588) 588
hodgkin disease - radiotherapy (585) 585
antineoplastic agents - pharmacology (581) 581
bleomycin - therapeutic use (573) 573
antineoplastic agents - administration & dosage (563) 563
hodgkin disease - pathology (557) 557
testicular neoplasms - drug therapy (557) 557
hematology (550) 550
cisplatin - adverse effects (533) 533
vinblastine - metabolism (530) 530
cell line (523) 523
cisplatin - therapeutic use (523) 523
urinary bladder neoplasms - drug therapy (519) 519
carcinoma, non-small-cell lung - pathology (511) 511
drug resistance (506) 506
bleomycin - adverse effects (496) 496
cisplatin (491) 491
antineoplastic agents, phytogenic - administration & dosage (490) 490
antineoplastic agents, phytogenic - therapeutic use (489) 489
antineoplastic agents, phytogenic - pharmacology (485) 485
biochemistry & molecular biology (485) 485
cyclophosphamide - therapeutic use (485) 485
vincristine - therapeutic use (485) 485
tumor cells, cultured (484) 484
kinetics (482) 482
breast neoplasms - pathology (477) 477
paclitaxel - administration & dosage (468) 468
research (456) 456
care and treatment (454) 454
clinical trials as topic (450) 450
doxorubicin - adverse effects (445) 445
chemotherapy, adjuvant (444) 444
mechlorethamine - administration & dosage (425) 425
prospective studies (404) 404
prednisone - therapeutic use (402) 402
methotrexate - therapeutic use (401) 401
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12113) 12113
Japanese (531) 531
French (411) 411
German (317) 317
Russian (198) 198
Italian (140) 140
Chinese (126) 126
Spanish (100) 100
Polish (79) 79
Hungarian (20) 20
Dutch (15) 15
Czech (14) 14
Portuguese (11) 11
Hebrew (10) 10
Romanian (7) 7
Bulgarian (6) 6
Danish (5) 5
Serbian (5) 5
Korean (4) 4
Finnish (3) 3
Croatian (2) 2
Lithuanian (2) 2
Slovak (2) 2
Turkish (2) 2
Afrikaans (1) 1
Arabic (1) 1
Icelandic (1) 1
Norwegian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1525 - 1531
Summary Background Use of cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has the potential to increase survival in... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptor, Epidermal Growth Factor - drug effects | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Young Adult | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Aged, 80 and over | Adult | Female | Cetuximab | Carcinoma, Non-Small-Cell Lung - pathology | Proportional Hazards Models | Survival Rate | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Chemotherapy | Research | Comparative analysis | Lung cancer, Non-small cell | Drug therapy | Health aspects | Cancer | Drugs | Studies | Data analysis | Lung cancer | Acne | Monoclonal antibodies | Clinical medicine | Kinases | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9796, pp. 1079 - 1088
Summary Background Platinum-based doublet chemotherapy is recommended to treat advanced non-small-cell lung cancer (NSCLC) in fit, non-elderly adults, but... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Carboplatin - adverse effects | Carcinoma, Squamous Cell - mortality | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Paclitaxel - administration & dosage | Drug Administration Schedule | Deoxycytidine - administration & dosage | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Survival Rate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Clinical trials | Chemotherapy | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus | Adenocarcinoma | Vinblastine | Carcinoma, Non-Small-Cell Lung | Antineoplastic Agents | Antineoplastic Combined Chemotherapy Protocols | Lung Neoplasms | Carcinoma, Squamous Cell | Life Sciences | Deoxycytidine | Paclitaxel | Carboplatin | Cancer
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2016, Volume 374, Issue 25, pp. 2419 - 2429
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 01/2011, Volume 29, Issue 3, pp. 264 - 271
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 08/2016, Volume 113, Issue 35, pp. 9691 - 9698
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 01/2008, Volume 130, Issue 2, pp. 420 - 421
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2018, Volume 378, Issue 4, pp. 331 - 344
Journal Article